Wild-type (senile) amyloidosis MRI: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Wild-type (senile) amyloidosis}} {{CMG}} ==Overview== ==MRI== ==References== {{Reflist|2}} Category:Disease Category:Cardiology [[Category:Pulmonology]...")
 
No edit summary
Line 6: Line 6:


==MRI==
==MRI==
===Cardiovascular Magnetic Resonance (CMR)===
*T1 sequence of CMR with the use of gadolinium can differentiate extracellular tissue thickening due to myocardial hypertrophy vs. extracellular deposition.
*Using pre- and post-contrast T1 mapping, extracellular volume (ECV) can be calculated, which is a direct measurement of the cardiac interstitium.<ref>{{Cite journal
| author = [[Francois-Pierre Mongeon]], [[Michael Jerosch-Herold]], [[Otavio Rizzi Coelho-Filho]], [[Ron Blankstein]], [[Rodney H. Falk]] & [[Raymond Y. Kwong]]
| title = Quantification of extracellular matrix expansion by CMR in infiltrative heart disease
| journal = [[JACC. Cardiovascular imaging]]
| volume = 5
| issue = 9
| pages = 897–907
| year = 2012
| month = September
| doi = 10.1016/j.jcmg.2012.04.006
| pmid = 22974802
}}</ref>
*ECV expansion is a quantitative marker of the amyloid burden and can detect amyloid fibrils infiltration earlier than conventional testing.


==References==
==References==

Revision as of 17:50, 19 December 2019

Wild-type (senile) amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Wild-type (senile) amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Wild-type (senile) amyloidosis MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Wild-type (senile) amyloidosis MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wild-type (senile) amyloidosis MRI

CDC on Wild-type (senile) amyloidosis MRI

Wild-type (senile) amyloidosis MRI in the news

Blogs on Wild-type (senile) amyloidosis MRI

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Wild-type (senile) amyloidosis MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

MRI

Cardiovascular Magnetic Resonance (CMR)

  • T1 sequence of CMR with the use of gadolinium can differentiate extracellular tissue thickening due to myocardial hypertrophy vs. extracellular deposition.
  • Using pre- and post-contrast T1 mapping, extracellular volume (ECV) can be calculated, which is a direct measurement of the cardiac interstitium.[1]
  • ECV expansion is a quantitative marker of the amyloid burden and can detect amyloid fibrils infiltration earlier than conventional testing.


References

  1. Francois-Pierre Mongeon, Michael Jerosch-Herold, Otavio Rizzi Coelho-Filho, Ron Blankstein, Rodney H. Falk & Raymond Y. Kwong (2012). "Quantification of extracellular matrix expansion by CMR in infiltrative heart disease". JACC. Cardiovascular imaging. 5 (9): 897–907. doi:10.1016/j.jcmg.2012.04.006. PMID 22974802. Unknown parameter |month= ignored (help)